{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T21:40:13Z","timestamp":1722980413611},"reference-count":48,"publisher":"Impact Journals, LLC","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,18]]},"DOI":"10.18632\/oncotarget.17830","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T19:53:12Z","timestamp":1494618792000},"page":"47790-47800","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Xiao","family":"Han","sequence":"first","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, CBLPath, Sonic Healthcare, Rye Brook, NY 10573, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqi","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxuan","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1179\/102453312X13336169156014","article-title":"New developments in the management of diffuse large B-cell lymphoma","volume":"17","author":"Habermann","year":"2012","journal-title":"Hematology"},{"key":"2","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Schmitz","year":"2010","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.clml.2015.02.029","article-title":"Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study","volume":"15","author":"Espeso","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00277-013-1807-0","article-title":"Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era","volume":"92","author":"Yu","year":"2013","journal-title":"Ann Hematol"},{"key":"5","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3109\/10428194.2014.893313","article-title":"Peripheral blood absolute lymphocyte\/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma","volume":"55","author":"Markovic","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"6","first-page":"934","article-title":"\u201c6 markers\/5 colors\u201d extended white blood cell differential by flow cytometry","volume":"71","author":"Feuillard","year":"2007","journal-title":"Cytometry A"},{"key":"7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3343\/alm.2015.35.1.28","article-title":"Flow cytometric white blood cell differential using CytoDiff is excellent for counting blasts","volume":"35","author":"Han","year":"2015","journal-title":"Ann Lab Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1751-553X.2012.01460.x","article-title":"Evaluation of CytoDiff\u2122 on cord blood WBC differential","volume":"35","author":"Roussel","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5045\/br.2014.49.2.120","article-title":"White blood cell differential counts in severely leukopenic samples: a comparative analysis of different solutions available in modern laboratory hematology","volume":"49","author":"Han","year":"2014","journal-title":"Blood Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/cytob.21123","article-title":"An extended leukocyte differential count (16 types of circulating leukocytes) using the CytoDiff flow cytometric system can provide information for the discrimination of sepsis severity and prediction of outcome in sepsis patients","volume":"86","author":"Chi","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"11","first-page":"58","article-title":"[The application of panel CytoDiff for monitoring of effectiveness of antiviral therapy in HIV-infected patients]. [Article in Russian]","volume":"59","author":"Tse\u012dlikman","year":"2014","journal-title":"Klin Lab Diagn"},{"key":"12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Mantovani","year":"2001","journal-title":"Lancet"},{"key":"13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2141.2008.07028.x","article-title":"Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma","volume":"141","author":"Monarca","year":"2008","journal-title":"Br J Haematol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/10428190802226425","article-title":"Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma","volume":"49","author":"Aloe-Spiriti","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/clpt.2009.254","article-title":"Inflammation and cancer: causes and consequences","volume":"87","author":"Clarke","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"16","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2011.112","article-title":"The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma","volume":"25","author":"Porrata","year":"2011","journal-title":"Leukemia"},{"key":"17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/annonc\/mdm110","article-title":"Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma","volume":"18","author":"Emile","year":"2007","journal-title":"Ann Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2001.19.3.720","article-title":"Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome","volume":"19","author":"Witzig","year":"2001","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2141.2007.06593.x","article-title":"The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma","volume":"137","author":"Andersson","year":"2007","journal-title":"Br J Haematol"},{"key":"20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.leu.2403240","article-title":"Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas","volume":"18","author":"Oudejans","year":"2004","journal-title":"Leukemia"},{"key":"21","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","article-title":"Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project","volume":"103","author":"Fuchs","year":"2004","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1309\/AJCPUJGMVV6ZF4GG","article-title":"High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma","volume":"144","author":"Chang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Albelda","year":"2009","journal-title":"Cancer Cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Mantovani","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajh.21849","article-title":"Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil\/lymphocyte ratio","volume":"85","author":"Markovic","year":"2010","journal-title":"Am J Hematol"},{"key":"26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bjc.2013.763","article-title":"The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"110","author":"Pichler","year":"2014","journal-title":"Br J Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ajh.23566","article-title":"The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy","volume":"88","author":"Devizzi","year":"2013","journal-title":"Am J Hematol"},{"key":"28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00277-013-1916-9","article-title":"Peripheral blood lymphocyte\/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens","volume":"93","author":"Zhai","year":"2014","journal-title":"Ann Hematol"},{"key":"29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2407-14-341","article-title":"Peripheral blood lymphocyte\/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma","volume":"14","author":"Zhai","year":"2014","journal-title":"BMC Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Shortman","year":"2010","journal-title":"Blood"},{"key":"31","first-page":"823","article-title":"CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) \/CD16(neg) monocytes: expansion of CD14(hi) \/CD16(pos) and contraction of CD14(lo) \/CD16(pos) monocytes in acute liver failure","volume":"81","author":"Vergani","year":"2012","journal-title":"Cytometry A"},{"key":"32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.imbio.2012.09.003","article-title":"Elevated markers of inflammation and endothelial activation and increased counts of intermediate monocytes in adult survivors of childhood acute lymphoblastic leukemia","volume":"218","author":"Grodzicki","year":"2013","journal-title":"Immunobiology"},{"key":"33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","article-title":"Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors","volume":"8","author":"Naldini","year":"2005","journal-title":"Cancer Cell"},{"key":"34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2249.2010.04200.x","article-title":"Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma","volume":"161","author":"Wongkham","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/labinvest.3700697","article-title":"Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy","volume":"88","author":"Natkunam","year":"2008","journal-title":"Lab Invest"},{"key":"36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/annonc\/mdn666","article-title":"Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma","volume":"20","author":"Leonard","year":"2009","journal-title":"Ann Oncol"},{"key":"37","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Gascoyne","year":"2005","journal-title":"Blood"},{"key":"38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"Coussens","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"viii6","DOI":"10.1093\/annonc\/mds256","article-title":"Immuno-oncology: understanding the function and dysfunction of the immune system in cancer","volume":"23","author":"Finn","year":"2012","journal-title":"Ann Oncol"},{"key":"40","first-page":"552","article-title":"Refining the white blood cell differential: the first flow cytometry routine application","volume":"77","author":"Fest","year":"2010","journal-title":"Cytometry A"},{"key":"41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-230X(03)90004-2","article-title":"Natural killer cells and cancer","volume":"90","author":"Lanier","year":"2003","journal-title":"Adv Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/eji.200939937","article-title":"Requirements for control of B-cell lymphoma by NK cells","volume":"40","author":"Mocikat","year":"2010","journal-title":"Eur J Immunol"},{"key":"43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1084\/jem.20031981","article-title":"Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells","volume":"199","author":"Smyth","year":"2004","journal-title":"J Exp Med"},{"key":"44","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Vardiman","year":"2008"},{"key":"45","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas","volume":"17","author":"Hiddemann","year":"1999","journal-title":"J Clin Oncol"},{"key":"46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Lister","year":"2007","journal-title":"J Clin Oncol"},{"key":"47","volume-title":"Evaluation of diagnostic systems: methods for signal detection theory","author":"Swets","year":"1982"},{"key":"48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Pepe","year":"2000","journal-title":"Biometrics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T20:46:08Z","timestamp":1589143568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":48,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017,7,18]]}},"alternative-id":["17830","28548962"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17830","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}